[Skip to Content]
[Skip to Content Landing]
Views 607
Citations 0
Correction
Dec 2012

Error in Reported Percentage in: Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell Carcinoma

Arch Dermatol. 2012;148(12):1376. doi:10.1001/jamadermatol.2013.2284

Error in Reported Percentage. In the Research Letter titled “Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell Carcinoma” by Chang and Oro, published in the November issue of the Archives (2012;148[11]:1324-1325), an incorrect percentage was reported in the second sentence of the “Results” section. That correct percentage is 5%, and so the sentence should read as follows: “The BCCs with regrowth represented 5% of all BCCs (including laBCCs, mBCCs, and nonadvanced BCCs) observed during vismodegib treatment (12 of 152) (Table).”

×